Alteration of Clot Architecture Using Bone Substitute Biomaterials (Beta-Tricalcium Phosphate) Significantly Delays the Early Bone Healing Process

Xin Wang,Yan Luo,Yan Yang,Baoyu Zheng,Fuhua Yan,Fei Wei,Thor E. Friis,Ross W. Crawford,Yin Xiao
DOI: https://doi.org/10.1039/c8tb01747f
IF: 7.571
2018-01-01
Journal of Materials Chemistry B
Abstract:When a bone substitute biomaterial is implanted into the body, the material's surface comes into contact with circulating blood, which results in the formation of a peri-implant hematoma or blood clot. Although hematoma formation is vital for the early bone healing process, knowledge concerning the biomaterial-induced structural properties of blood clots is limited. Here, we report that implantation of beta-tricalcium phosphate (β-TCP) in a bone defect healing model in rats resulted in significantly delayed early bone healing compared to empty controls (natural healing). In vitro studies showed that β-TCP had a profound effect on the overall structure of hematomas, as was observed by fibrin turbidity, scanning electron microscopy (SEM), compaction assays, and fibrinolysis. Under the influence of β-TCP, clot formation had a significantly shortened lag time and there was enhanced lateral fibrin aggregation during the clot polymerization, which resulted in clots composed of thinner fibers. Furthermore, fibrin clots that formed around β-TCP exhibited reduced compaction and increased resistance to fibrinolysis. Together, these results provide a plausible mechanism for how implanted bone-substitute materials may impact the structural properties of the hematoma, thereby altering the early bone healing processes, such as cell infiltration, growth factor release and angiogenesis.
What problem does this paper attempt to address?